bioRxiv Science⌕ Search

Biology subjects

Dippel, A.

Publications and source records attributed to Dippel, A..

2 recordsLinked to original sources

Predicting Antibody Self-Association with Sequence Structure Fusion Models: The Central Role of CSI-BLI in Early Developability Screening

Antibody-based biologics are expanding rapidly, yet challenges in development from self-association, high viscosity, aggregation, and unfavorable clearance underscore the need for accurate in silico screening. Clone self-interaction biolayer interferometry (CSI-BLI) is a plate-based, low-material assay of weak, reversible self-association that serves as an early proxy for high-concentration viscosity and a complementary predictor of in vivo clearance. In a 246-mAb panel, CSI-BLI moderately correlates with viscosity; further, in hFcRn Tg32 mice (41 antibodies), CSI-BLI strongly associates with clearance. Here, we present an end-to-end framework that distinguishes high versus low self-interacting clones (CSI-BLI class) by coupling a fine-tuned protein language model (ESM-2) with residue-aligned 3D context from AlphaFold-predicted structures encoded as residue graphs. Disentangled multi-stream attention fuses sequence content, chain-aware positional information, and structural signals to capture spatially proximate interactions that are distant in sequence. Edit-distance-controlled splits across 1499 IgGs and 988 VHHs assess generalization. The structure-aware model achieves the highest hold-out performance (VHH-Fc F1 = 0.76; IgG F1 = 0.57), while a sequence-only disentangled variant outperforms a standard PLM baseline without structural inputs. Complementary biophysical feature-based models, built from AlphaFold structures and sequence/structure-derived physicochemical descriptors with cluster-aware selection, deliver robust, interpretable performance (VHH F1 = 0.72; IgG F1 = 0.57), with SHAP analyses highlighting charge/dipole, hydrophobicity, and aggregation-propensity drivers across CDRs and frameworks. This interaction-aware sequence-structure framework, supported by interpretable feature models, is extensible to other developability endpoints and broader protein classification tasks where joint modeling of language-derived representations and residue-level geometry is advantageous.

bioinformatics↗

Enhancement of antibody thermostability and affinity by computational design in the absence of antigen

Over the last two decades, therapeutic antibodies have emerged as a rapidly expanding domain within the field biologics. In silico tools that can streamline the process of antibody discovery and optimization are critical to support a pipeline that is growing more numerous and complex every year. In this study, DeepAb, a deep learning model for predicting antibody Fv structure directly from sequence, was used to design 200 potentially stabilized variants of an anti-hen egg lysozyme (HEL) antibody. We sought to determine whether DeepAb can enhance the stability of these antibody variants without relying on or predicting the antibody-antigen interface, and whether this stabilization could increase antibody affinity without impacting their developability profile. The 200 variants were produced through a robust highthroughput method and tested for thermal and colloidal stability (Tonset, Tm, Tagg), affinity (KD) relative to the parental antibody, and for developability parameters (non-specific binding, aggregation propensity, self-association). In the designed clones, 91% and 94% exhibited increased thermal and colloidal stability and affinity, respectively. Of these, 10% showed a significantly increased affinity for HEL (5-to 21-fold increase), with most clones retaining the favorable developability profile of the parental antibody. These data open the possibility of in silico antibody stabilization and affinity maturation without the need to predict the antibody-antigen interface, which is notoriously difficult in the absence of crystal structures.

molecular biology↗